134 related articles for article (PubMed ID: 2510277)
41. Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa.
Garner A; Flemström G; Heylings JR
Gastroenterology; 1979 Sep; 77(3):451-7. PubMed ID: 313351
[TBL] [Abstract][Full Text] [Related]
42. Studies of the 'mucus-bicarbonate' barrier on rat fundic mucosa: the effects of luminal pH and a stable prostaglandin analogue.
Ross IN; Turnberg LA
Gut; 1983 Nov; 24(11):1030-3. PubMed ID: 6629112
[TBL] [Abstract][Full Text] [Related]
43. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
44. Effect of carbenoxolone on alkaline secretion by isolated amphibian gastric and duodenal mucosa.
Rees WD; Garner A; Heylings JR; Flemström G
Eur J Clin Invest; 1981 Dec; 11(6):481-6. PubMed ID: 6800823
[TBL] [Abstract][Full Text] [Related]
45. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
Baunack AR; Demol P; Froese G; Kuhlmann J; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():120-5; discussion 125-6. PubMed ID: 2510255
[TBL] [Abstract][Full Text] [Related]
46. Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage.
Takeuchi K; Ueki S; Tanaka H
Am J Physiol; 1986 Jun; 250(6 Pt 1):G842-9. PubMed ID: 3459368
[TBL] [Abstract][Full Text] [Related]
47. Lipoxygenase metabolites in the rat gastric microvascular response to intragastric ethanol.
Yonei Y; Guth PH
Gastroenterology; 1989 Aug; 97(2):304-12. PubMed ID: 2501140
[TBL] [Abstract][Full Text] [Related]
48. Effects of SCH 32651 on resting and stimulated acid secretion in guinea-pig isolated fundic mucosa.
Barnett A; Chiu PJ; Tetzloff G
Br J Pharmacol; 1984 Sep; 83(1):75-82. PubMed ID: 6091829
[TBL] [Abstract][Full Text] [Related]
49. Rioprostil, a new prostaglandin E1, prevents cyclosporin A-induced damage to endocrine and exocrine pancreas.
Müller M; Degenhardt H; Bergmann K; Coone H; Löhr M; Klöppel G; Goebell H
Scand J Gastroenterol Suppl; 1989; 164():35-41. PubMed ID: 2510278
[TBL] [Abstract][Full Text] [Related]
50. Transcellular bicarbonate transport in rabbit gallbladder epithelium: mechanisms and effects of cyclic AMP.
Petersen KU; Wehner F; Winterhager JM
Pflugers Arch; 1990 May; 416(3):312-21. PubMed ID: 2166275
[TBL] [Abstract][Full Text] [Related]
51. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
Katz LB; Genna T; Greeley GH; Shriver DA
Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
[TBL] [Abstract][Full Text] [Related]
52. Stimulation of duodenal epithelial HCO3- transport in the guinea pig and cat by luminal prostaglandin E2.
Flemström G; Nylander O
Prostaglandins; 1981; 21 Suppl():47-52. PubMed ID: 6946525
[TBL] [Abstract][Full Text] [Related]
53. Gastroduodenal mucosal secretion of bicarbonate and mucus. Physiologic control and stimulation by prostaglandins.
Flemström G
Am J Med; 1986 Aug; 81(2A):18-22. PubMed ID: 3463207
[TBL] [Abstract][Full Text] [Related]
54. Effect of different prostaglandin analogues on gastric acid secretion and mucosal blood flow in the dog: action on stimulated and resting mucosa.
Bálint GA; Sági I; Döbrönte Z; Varró V
Acta Med Hung; 1984; 41(2-3):149-55. PubMed ID: 6379594
[TBL] [Abstract][Full Text] [Related]
55. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
56. Naloxone-insensitive transport effects of loperamide in guinea-pig gallbladder epithelium.
Wehner F; Winterhager JM; Petersen KU
Eur J Pharmacol; 1990 Mar; 178(3):333-42. PubMed ID: 2160371
[TBL] [Abstract][Full Text] [Related]
57. Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man.
Bjarnason I; Smethurst P; Clark P; Menzies I; Levi J; Peters T
Scand J Gastroenterol Suppl; 1989; 164():97-102; discussion 102-3. PubMed ID: 2510288
[TBL] [Abstract][Full Text] [Related]
58. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
59. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
Vantrappen G; Janssens J
Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of the effects of prostaglandins and H2-receptor antagonists on gastric acid secretion, mucosal blood flow and ulcer formation.
Banerjee AK; Christmas AJ; Hall CE
Arzneimittelforschung; 1979; 29(4):634-9. PubMed ID: 39581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
